The Heart Transplant market is accruing owing to the advancements of surgical techniques, immunosuppressive modalities, and postoperative care. Growing prevalence of Heart failures and heart related diseases are boosting the revenues in the heart transplantation sector per year. In recent years, lower availability of donors has prompted significant investments in R&D activities to invent advent technologies and new surgical techniques. These investments in turn are defining the immense growth landscape of the Heart Transplant market.
According to the registry of the International Society for Heart and Lung Transplantation, approximately 500-600 pediatric heart transplantation procedures are performed globally every year, which represents around 12% of the total number of heart transplants performed. And in 2014, a total number of children heart transplants execute globally was 586. In children, the most often caused of heart failure is occurred owing to a congenital heart defect or a cardiomyopathy.
The Global Heart Transplant Market is expected to grow at a CAGR of 11.2% during the forecast period of 2017-2023.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1836
Key Players for Global Heart Transplant Market
SynCardia Systems, LLC (U.S.), HeartWare International Inc., Apaxis Medical, Inc., Calon Cardio, Optum Inc. (U.S.), Thoratec Corporation (U.S.), CardiacAssist Inc. (U.S.), CARMAT (France) and others.
Heart Transplant Industry News:
February 2017 – The University of Pittsburgh Medical Center and Microsoft announced their partnership launching an initiative to build three specialty hospitals with a digital focus. UPMC declared the investment of USD 2 billion to add three tech-based hospitals to its healthcare system in Pittsburgh, including the UPMC Heart and Transplant Hospital, UPMC Hillman Cancer Hospital and UPMC Vision and Rehabilitation Hospital. Microsoft will act as creative force for developing the digital hospitals in this collaboration providing developers and leveraging its digital tools.
March 2017 – Research Team at the University of Minnesota, announced that they have discovered a groundbreaking process to successfully re-warm large-scale animal heart valves and blood vessels preserved at very low temperatures. The discovery is a major step forward in saving millions of human lives by increasing the availability of organs and tissues for transplantation through the establishment of tissue and organ banks.
November 2017 – Doctors at the Cleveland Clinic revealed the new understanding of cholesterol after a number of trials that have recently shown a 20 percent reduction in the risk of cardiovascular death, heart attack, and stroke in patients who took statins combined with a new class of cholesterol-lowering drugs (PCSK9 inhibitors) to reach ultra-low LDL levels. This means now, doctors will have the tools and the research to take the fight to LDL cholesterol. With over 400,000 coronary disease deaths and 102 million Americans living with high cholesterol levels, these new strategies hold the promise to turn the tide in 2018.
Regional Analysis for Global Heart Transplant Market
The Americas dominate the global heart transplant market owing to well-developed technology, high health care spending, increasing government support for research & development, and increasing patient with coronary artery disease, heart valve disease, and cardiomyopathy. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region. According to the International Society for Heart and Lung Transplantation in 2016, total heart transplants in the U.S. were performed in patients up to 17 years of age is 444.
Europe holds the second position in the global heart transplantation market owing to the government support for research & development and availability of funds for research. This is expected to continue driving the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.
Asia Pacific is the fastest growing health transplantation market owing to the presence of rapidly developing healthcare technology and high healthcare expenditure. Moreover, lower treatment cost as compared to developed countries attract global patients to the countries like India and China market. Furthermore, increasing demand for quality devices in the healthcare is projected to lead to the use of advanced equipment, which, in turn, is likely to increase the growth of the heart transplantation market in the region.
On the other hand, the Middle East and Africa account for the least market owing to poor political conditions in Africa and limited availability of funds and medical facilities. The Middle East holds the major share of the Middle East & Africa region due to the presence of well-developed countries like Kuwait, Qatar, Oman, and South Arabia.
Some Brief Table of Contents of Report
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope Of The Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/1836
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar